retatrutide trial data 24.2% body weight lost at 48 weeks. Not by eating less. By burning more at rest. is a triple agonist: a single synthetic peptide that simultaneously engages three receptors — GLP-1R Retatrutide for weight loss: Study

In contrast, in the injured liver, HSCs are regarded as the primary target cells for inflammatory and oxidative stimuli, and they are proliferated, enlarged and transformed into myofibroblast-like cells

Because the recipes vary by pharmacy, the label matters more than the name

While tirzepatide's primary indications focus on metabolic health, its effects on weight loss and glycemic control may have secondary benefits for various obesity- and diabetes-related complications, though cardiovascular outcome trials are still ongoing

Ketone bodies inhibit the viability of human neuroblastoma cells

3163 NAION (visionloss) Allegations A separate proceeding, MDL 3163, addresses claims that GLP1 therapies caused nonarteritic anterior ischemic optic neuropathy (NAION), a condition associated with sudden vision loss